Petra Krabisch Selected Research

Cachexia

1/2018

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Petra Krabisch Research Topics

Disease

16	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2012
7	Neoplasms (Cancer) 11/2023 - 02/2012
3	Neutropenia 02/2021 - 07/2013
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2018
2	Infections 02/2021 - 07/2013
2	Thrombocytopenia (Thrombopenia) 01/2018 - 07/2013
1	Pathologic Complete Response 01/2023
1	Febrile Neutropenia 02/2021
1	Musculoskeletal Pain 10/2019
1	Arthralgia (Joint Pain) 10/2019
1	Pain (Aches) 10/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Ascites 01/2018
1	Fever (Fevers) 01/2018
1	Alopecia (Baldness) 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Pulmonary Embolism 01/2018
1	Cachexia 01/2018
1	Disease Progression 01/2018
1	Sepsis (Septicemia) 01/2018
1	Inflammation (Inflammations) 07/2013
1	Exanthema (Rash) 07/2013
1	Circulating Neoplastic Cells 02/2012

Drug/Important Bio-Agent (IBA)

4	Hormones (Hormone)IBA 12/2023 - 04/2019
2	Letrozole (Femara)FDA LinkGeneric 12/2023 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2016
2	Bevacizumab (Avastin)FDA Link 01/2019 - 07/2013
2	Epirubicin (Ellence)FDA LinkGeneric 01/2019 - 07/2013
2	AnthracyclinesIBA 01/2019 - 01/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 07/2013
1	ribociclibIBA 12/2023
1	Epidermal Growth Factor (EGF)IBA 12/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	Denosumab FDA Link 01/2023
1	pegfilgrastim (Neulasta)FDA Link 02/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2020
1	Aromatase InhibitorsIBA 10/2019
1	eribulin FDA Link 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Carbonic Anhydrase IXIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	PlatinumIBA 01/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2013
1	Everolimus FDA Link 07/2013
1	taxaneIBA 01/2013
1	Messenger RNA (mRNA)IBA 02/2012
1	AntibodiesIBA 02/2012

Therapy/Procedure

5	Therapeutics 11/2023 - 10/2017
5	Drug Therapy (Chemotherapy) 02/2021 - 10/2017
3	Neoadjuvant Therapy 01/2023 - 01/2013
1	Aftercare (After-Treatment) 11/2023
1	Adjuvant Chemotherapy 02/2021
1	Precision Medicine 02/2012